1. Home
  2. MBINM vs VCEL Comparison

MBINM vs VCEL Comparison

Compare MBINM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBINM

Merchants Bancorp

N/A

Current Price

$25.46

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBINM
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
663
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
MBINM
VCEL
Price
$25.46
$37.77
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.50
AVG Volume (30 Days)
N/A
577.0K
Earning Date
N/A
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$147.15
Revenue Growth
N/A
14.05
52 Week Low
N/A
$29.24
52 Week High
N/A
$63.00

Technical Indicators

Market Signals
Indicator
MBINM
VCEL
Relative Strength Index (RSI) 57.19 50.84
Support Level $25.10 $35.85
Resistance Level $25.64 $39.07
Average True Range (ATR) 0.23 1.82
MACD -0.02 -0.07
Stochastic Oscillator 46.75 39.08

Price Performance

Historical Comparison
MBINM
VCEL

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: